Air Liquide bags contract in Spain to care for patients living with respiratory conditions at home
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
Subscribe To Our Newsletter & Stay Updated